These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 29712884)

  • 41. [Gut microbiota: Description, role and pathophysiologic implications].
    Landman C; Quévrain E
    Rev Med Interne; 2016 Jun; 37(6):418-23. PubMed ID: 26749318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Gut microflora and metabolic syndrome: new insight into the pathogenesis of hypertension].
    Mukohda M; Mizuno R; Ozaki H
    Nihon Yakurigaku Zasshi; 2022; 157(5):311-315. PubMed ID: 36047142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intestinal Dysbiosis and Rheumatoid Arthritis: A Link between Gut Microbiota and the Pathogenesis of Rheumatoid Arthritis.
    Horta-Baas G; Romero-Figueroa MDS; Montiel-Jarquín AJ; Pizano-Zárate ML; García-Mena J; Ramírez-Durán N
    J Immunol Res; 2017; 2017():4835189. PubMed ID: 28948174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Obstructive Sleep Apnea-Induced Hypertension: Role of the Gut Microbiota.
    Durgan DJ
    Curr Hypertens Rep; 2017 Apr; 19(4):35. PubMed ID: 28365886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gut Epithelial Metabolism as a Key Driver of Intestinal Dysbiosis Associated with Noncommunicable Diseases.
    Shelton CD; Byndloss MX
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32122941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-inflammatory mechanisms of polyphenols in adipose tissue: role of gut microbiota, intestinal barrier integrity and zinc homeostasis.
    Islam T; Albracht-Schulte K; Ramalingam L; Schlabritz-Lutsevich N; Park OH; Zabet-Moghaddam M; Kalupahana NS; Moustaid-Moussa N
    J Nutr Biochem; 2023 May; 115():109242. PubMed ID: 36442715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Linking gut microbiota to cardiovascular disease and hypertension: Lessons from chronic kidney disease.
    Meijers B; Jouret F; Evenepoel P
    Pharmacol Res; 2018 Jul; 133():101-107. PubMed ID: 29715498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut Microbiota and Type 1 Diabetes.
    Han H; Li Y; Fang J; Liu G; Yin J; Li T; Yin Y
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29584630
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
    Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
    World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular Paths Linking Metabolic Diseases, Gut Microbiota Dysbiosis and Enterobacteria Infections.
    Serino M
    J Mol Biol; 2018 Mar; 430(5):581-590. PubMed ID: 29374557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis.
    Song H; Yoo Y; Hwang J; Na YC; Kim HS
    J Allergy Clin Immunol; 2016 Mar; 137(3):852-60. PubMed ID: 26431583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Role of the Gut Microbiota in Bile Acid Metabolism.
    Ramírez-Pérez O; Cruz-Ramón V; Chinchilla-López P; Méndez-Sánchez N
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s15-s20. PubMed ID: 29080339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.
    Sitkin SI; Tkachenko EI; Vakhitov TY
    Eksp Klin Gastroenterol; 2016 Jul; 12(12):6-29. PubMed ID: 29889418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Helminths and Intestinal Flora Team Up to Improve Gut Health.
    Giacomin P; Agha Z; Loukas A
    Trends Parasitol; 2016 Sep; 32(9):664-666. PubMed ID: 27234811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alterations of the Gut Microbiome in Hypertension.
    Yan Q; Gu Y; Li X; Yang W; Jia L; Chen C; Han X; Huang Y; Zhao L; Li P; Fang Z; Zhou J; Guan X; Ding Y; Wang S; Khan M; Xin Y; Li S; Ma Y
    Front Cell Infect Microbiol; 2017; 7():381. PubMed ID: 28884091
    [No Abstract]   [Full Text] [Related]  

  • 56. Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications.
    Natividad JM; Verdu EF
    Pharmacol Res; 2013 Mar; 69(1):42-51. PubMed ID: 23089410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intestinal dysbiosis activates renal renin-angiotensin system contributing to incipient diabetic nephropathy.
    Lu CC; Ma KL; Ruan XZ; Liu BC
    Int J Med Sci; 2018; 15(8):816-822. PubMed ID: 30008592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The possible mechanisms of the human microbiome in allergic diseases.
    Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
    Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
    Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.